366 related articles for article (PubMed ID: 23041003)
21. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients.
Wu CC; Liou HH; Su PF; Chang MY; Wang HH; Chen MJ; Hung SY
Nephrol Dial Transplant; 2011 Nov; 26(11):3689-95. PubMed ID: 21357211
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
Kastorini CM; Panagiotakos DB; Georgousopoulou EN; Laskaris A; Skourlis N; Zana A; Chatzinikolaou C; Chrysohoou C; Puddu PE; Tousoulis D; Stefanadis C; Pitsavos C;
Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):223-31. PubMed ID: 26803591
[TBL] [Abstract][Full Text] [Related]
23. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO.
Ma WY; Li HY; Hung CS; Lin MS; Chiu FC; Lin CH; Shih SR; Chuang LM; Wei JN
Diabetes Res Clin Pract; 2009 Sep; 85(3):335-41. PubMed ID: 19608293
[TBL] [Abstract][Full Text] [Related]
25. Diagnosing metabolic syndrome in type 2 diabetic Turkish patients: comparison of AHA/NHLBI and IDF definitions.
Basol G; Barutcuoglu B; Cakir Y; Ozmen B; Parildar Z; Kose T; Ozmen D; Bayindir O
Bratisl Lek Listy; 2011; 112(5):253-9. PubMed ID: 21682078
[TBL] [Abstract][Full Text] [Related]
26. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
[TBL] [Abstract][Full Text] [Related]
27. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
28. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome and all-cause mortality in older men and women.
Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
31. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
[TBL] [Abstract][Full Text] [Related]
32. Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population.
Wen J; Yang J; Shi Y; Liang Y; Wang F; Duan X; Lu X; Tao Q; Lu X; Tian Y; Wang N
PLoS One; 2015; 10(5):e0126832. PubMed ID: 25961739
[TBL] [Abstract][Full Text] [Related]
33. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
34. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population.
Hadaegh F; Ghasemi A; Padyab M; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2008 May; 80(2):328-34. PubMed ID: 18282630
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome components and prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
Tan MC; Wong TW; Ng OC; Joseph A; Hejar AR
Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):226-35. PubMed ID: 24964674
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Song SH; Hardisty CA
QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
[TBL] [Abstract][Full Text] [Related]
38. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
DECODE Study Group
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
[TBL] [Abstract][Full Text] [Related]
39. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
40. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
